Instructor in Medicine, Brigham and Women's Hospital
Cardiology
Dr. Marc P. Bonaca, MD
|
|
Give Review
Doctor Marc P. Bonaca, MD is an expert in the field of Cardiology. He researched medicine at University of Connecticut School of Medicine. University of Connecticut School of Medicine is ranked 60/49 in Research/PrimaryCare. He received 1 awards: "Meaningful Use Stage 1 Certification". Marc Bonaca is a published doctor. He published 34 publications, including: 'Platelet Inhibition With Ticagrelor 60mgVersus 90 mg Twice Daily in thePEGASUS-TIMI 54 Trial.' Marc Bonaca accepts Medicare.
Publications
- Outcomes in Stable Patients With Previous Atherothrombotic Events Receiving Vorapaxar Who Experience a New Acute Coronary Event (from TRA2°P-TIMI 50).
- Efficacy and Safety of Vorapaxar With and Without a Thienopyridine for Secondary Prevention in Patients With Previous Myocardial Infarction and No History of Stroke or...
- Ischaemic risk and efficacy of ticagrelor in relation to time from P2Y12 inhibitor withdrawal in patients with prior Myocardial infarction: insights from PEGASUS-TIMI 54.
- Vorapaxar in Patients With Diabetes Mellitus and Previous Myocardial Infarction: Findings From the Thrombin Receptor Antagonist in Secondary Prevention of Atherothromb...
- Prognostic Implications of Low Level Cardiac Troponin Elevation Using High-Sensitivity Cardiac Troponin T.
- Long-Term Use of Ticagrelor in Patients with Prior Myocardial Infarction.
- Coronary Stent Thrombosis With Vorapaxar Versus Placebo: Results From the TRA 2°P-TIMI 50 Trial.
- New Ischemic Stroke and Outcomes With Vorapaxar Versus Placebo: Results From the TRA 2°P-TIMI 50 Trial.
- Diagnosis and management of Acute aortic syndromes: dissection, intramural hematoma, and penetrating aortic ulcer.
- Effect of darapladib on major coronary events after an Acute coronary syndrome: the SOLID-TIMI 52 randomized clinical trial.
- Patterns of Long-term Thienopyridine Therapy and Outcomes in Patients With Acute Coronary Syndrome Treated With Coronary Stenting: Observations From the TIMI-38 Corona...
- Diagnostic Performance of Copeptin in Patients With Acute Nontraumatic Chest Pain: BWH-TIMI ED Chest Pain Study.
- Clinical Features, Use of Evidence-Based Therapies, and Cardiovascular Outcomes Among Patients With Chronic Kidney Disease Following Non-ST-Elevation Acute Coronary Sy...
- Erratum to: Evaluation of the diagnostic performance of Heart-type fatty acid binding protein in the BWH-TIMI ED chest pain study.
- Ticagrelor for Acute coronary syndromes.
- Real-world application of "delta" troponin: diagnostic and prognostic implications.
- Evaluation of the diagnostic performance of current and next-generation assays for cardiac troponin I in the BWH-TIMI ED Chest Pain Study.
- Vorapaxar in Patients With Peripheral Artery Disease: Results From TRA2{degrees}P-TIMI 50.
- Management of Asymptomatic Carotid Artery Stenosis.
- Efficacy and safety of vorapaxar in patients with prior ischemic stroke.
- Evaluation of the diagnostic performance of Heart-type fatty acid binding protein in the BWH-TIMI ED chest pain study.
- Prospective evaluation of pregnancy-associated plasma protein-a and outcomes in patients with Acute coronary syndromes.
- ACC/AHA/ESC/WHF Universal Definition of Myocardial Infarction Classification System and the Risk of Cardiovascular Death: Observations from the TRITON-TIMI 38 Trial.
- Role of ST2 in Non-ST-Elevation Acute Coronary Syndrome in the MERLIN-TIMI 36 Trial.
- Central obesity and cardiovascular outcomes in patients with Acute coronary syndrome: observations from the MERLIN-TIMI 36 trial.
- Growth differentiation factor-15 and risk of recurrent events in patients stabilized after Acute coronary syndrome: observations from PROVE IT-TIMI 22.
- Antithrombotics in Acute coronary syndromes.
- Effect of the novel thienopyridine prasugrel compared with clopidogrel on spontaneous and procedural Myocardial infarction in the Trial to Assess Improvement in Therap...
- Glycoprotein IIb-IIIa inhibitors in the emergency department for patients with non-ST-elevation Acute coronary syndromes: principles and practices.
- Defining a role for novel biomarkers in Acute coronary syndromes.
- Hemodynamic significance of periprocedural myocardial injury assessed with N-terminal pro-B-type natriuretic peptide after percutaneous Coronary intervention in patien...
- Efficacy and safety of vorapaxar as approved for clinical use in the United States.
- Platelet Inhibition With Ticagrelor 60 mg Versus 90 mg Twice Daily in the PEGASUS-TIMI 54 Trial.
Schools
Univ Of Ct Sch Of Med
Brigham and Women39s Hospital
Procedures Preformed
- Ablation for Treatment of Cardiac Arrhythmias
- Cardiac Catheterization (incl. Coronary Angiography)
- Cardiac Imaging
- Cardiac Myocardial Perfusion Imaging
- View All
Conditions Treated
- Angina and Acute Coronary Syndrome
- Aortic Aneurysm
- Aortic Dissection
- Aortic Valve Disease
- View All
Doctors Specialties
- Cardiology
Accepted Insurances
Awards
- Meaningful Use Stage 1 Certification
Education
-
Brigham and Women's Hospital -
University of Connecticut School of Medicine
Hospital
-
Brigham and Women's Hospital
Drug Facts
| NPI NUMBER | 1598834590 | |
| NPPES Provider LastName | BONACA | |
| NPPES Provider FirstName | MARC | |
| NPPES Provider ZIPCode | 021156110 | |
| NPPES Provider State | MA | |
| Specialty Description | Cardiology | |
| Total Claim Count | 124.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1598834590 |
| Last Name Of The Provider | BONACA |
| First Name Of The Provider | MARC |
| View All |
Similar Doctors
|
|
Stanley Chia, MB CHB |
|
|
Dr. Edward T. Carreras, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sanjay Shrivastava, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Erin A. Bohula, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nicholas R. Balaji, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David M. Leder, MD |
|
|
Dr. Loryn S. Feinberg, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jacob A. Udell, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Eric A. Secemsky, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Themy F. Dumlao Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alawi A. Alsheikh-Ali, MD |
|
|
Dr. Zoran S. Nedeljkovic, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ivan Luptak Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Veerendra M. Chadachan
This Doctor is OpenDoctor Recommended.
|